GlassScriptPhysician profile
Candace Barker
NPI 1306216825
$18,222.12
in general payments reported to CMS, 2019-2025
71 companies · $4,729 in 2025
The $4,729 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,270 · 2022: $3,442 · 2023: $3,338 · 2024: $3,443 · 2025: $4,729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Honoraria: $788 · Education: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,168.36 |
| Honoraria | $787.50 |
| Education | $554.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,177.36 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,643.79 | 2021-2025 | Imfinzi, Calquence, Lynparza |
| Pharmaessentia USA Corporation | $1,163.08 | 2023-2025 | Besremi |
| Janssen Biotech, INC. | $1,150.76 | 2021-2025 | Darzalex, Erleada, Tecvayli |
| Pfizer INC. | $918.51 | 2021-2025 | |
| Galt Pharmaceuticals, LLC | $672.85 | 2023 | Orphengesic Forte, Oravig |
| Seagen INC. | $631.33 | 2021-2023 | Adcetris, Padcev, Tukysa |
| Incyte Corporation | $620.33 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Amgen INC. | $606.95 | 2021-2023 | Blincyto, Kyprolis |
| E.R. Squibb & Sons, L.L.C. | $580.04 | 2021-2025 | Opdivo, Opdualag, Krazati |
| Lilly USA, LLC | $568.91 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Merck Sharp & Dohme LLC | $520.46 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Genzyme Corporation | $458.43 | 2021-2025 | |
| Sobi, INC | $430.96 | 2022-2025 | |
| Abbvie INC. | $404.70 | 2021-2025 |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $380.66 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $338.90 | 2021-2025 | Fruzaqla, Ninlaro, Iclusig |
| Regeneron Healthcare Solutions, INC. | $328.68 | 2021-2025 | Libtayo, Lynozyfic |
| Celgene Corporation | $299.94 | 2021-2025 | Reblozyl, Opdualag, Pomalyst |
| Stemline Therapeutics INC. | $234.85 | 2023-2025 | Orserdu |
| Glaxosmithkline, LLC. | $233.01 | 2021-2025 | Jemperli, Ojjaara, Zejula |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.52 | 2021-2022 | |
| Eisai INC. | $211.92 | 2022-2025 | |
| Karyopharm Therapeutics INC. | $197.06 | 2021-2025 | Xpovio |
| Daiichi Sankyo INC. | $169.70 | 2021-2025 | Enhertu, Datroway |
| Puma Biotechnology, INC. | $156.85 | 2021-2025 | |
| Blueprint Medicines Corporation | $146.43 | 2021-2025 | Ayvakit |
| Array Biopharma INC | $138.84 | 2021-2025 | Mektovi, Braftovi, Tukysa |
| Gilead Sciences, INC. | $136.67 | 2022-2025 | Trodelvy |
| Beone Medicines USA, INC. | $136.60 | 2025 | Brukinsa, Tevimbra |
| Pharmacosmos Therapeutics INC. | $135.50 | 2025 | Monoferric |
| Beigene USA, INC. | $128.98 | 2022-2025 | Brukinsa, Tevimbra |
| Astellas Pharma US INC | $115.57 | 2022-2025 | Xtandi |
| Kite Pharma, INC. | $104.65 | 2021-2025 | Yescarta |
| Genentech USA, INC. | $100.86 | 2024-2025 | Polivy, Columvi, Lunsumio |
| Myriad Genetic Laboratories, INC. | $100.62 | 2021-2024 | Bracanalysis Cdx, Myrisk |
| Sumitomo Pharma America, INC. | $98.27 | 2024-2025 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $97.98 | 2022-2024 | |
| Genmab U.S., INC. | $94.93 | 2023-2025 | Epkinly |
| Rigel Pharmaceuticals, INC. | $82.12 | 2023-2025 | Rezlidhia, Tavalisse, Gavreto |
| Progenics Pharmaceuticals, INC. | $77.54 | 2021-2023 | Pylarify |
| Servier Pharmaceuticals LLC | $68.00 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $67.22 | 2021-2024 | Ultomiris |
| Aveo Pharmaceuticals, INC. | $66.61 | 2022-2024 | Fotivda |
| Emd Serono, INC. | $64.61 | 2023-2025 | Bavencio |
| Dova Pharmaceuticals | $64.23 | 2021 | |
| Novocure INC. | $63.80 | 2025 | Optune Lua (Novottf-200t) |
| Pharmacyclics LLC, An Abbvie Company | $62.89 | 2021-2022 | |
| Exelixis INC. | $51.09 | 2025 | Cabometyx |
| Coherus Oncology, INC. | $50.90 | 2022-2023 | |
| Atland Pharmaceuticals, LLC | $48.84 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Geron Corporation | $48.12 | 2025 | Rytelo |
| Spectrum Pharmaceuticals INC. | $46.81 | 2024-2025 | Rolvedon |
| Tempus Ai, INC | $44.40 | 2024 | |
| Global Blood Therapeutics, INC. | $41.64 | 2022 | |
| Myovant Sciences INC. | $40.45 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $40.36 | 2025 | Pyrukynd |
| Phathom Pharmaceuticals, INC. | $35.75 | 2025 | Voquezna |
| Adc Therapeutics America, INC. | $33.98 | 2022 | |
| Taiho Oncology, INC. | $33.58 | 2023 | |
| Sun Pharmaceutical Industries INC. | $30.54 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $29.13 | 2024 | Somatuline Depot, Onivyde |
| Iovance Biotherapeutics, INC. | $26.35 | 2024 | Amtagvi |
| Emmaus Medical, INC. | $26.17 | 2024 | Endari |
| Amag Pharmaceuticals, INC. | $24.44 | 2022 | |
| Tg Therapeutics, INC. | $19.17 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.60 | 2025 | Givlaari |
| Deciphera Pharmaceuticals INC. | $17.54 | 2024 | Qinlock |
| Adaptive Biotechnologies Corporation | $16.87 | 2024 | Clonoseq |
| Grifols USA, LLC | $15.13 | 2021 | |
| Shield Therapeutics INC | $14.79 | 2022 |
Drugs and devices associated with these payments
Besremi $1,163Imfinzi $802Oravig $673Orphengesic Forte $673Kisqali $464Darzalex $282Erleada $268Xtandi $243Keytruda $242Orserdu $235Jaypirca $229Tecvayli $220Lutathera $220Doptelet $215Verzenio $212Orgovyx $211Pluvicto $205Fruzaqla $205Adcetris $185Ayvakit $183Elrexfio $181Brukinsa $179Venclexta $171Tukysa $167Libtayo $167Scemblix $166Lenvima $160Padcev $156Epkinly $156Jakafi $156Talvey $155Imbruvica $152Calquence $146Reblozyl $142Rybrevant $142Monoferric $136Opdivo $131Lynparza $118Enhertu $118Bosulif $117Retevmo $112Zepzelca $111Oxbryta $111Talzenna $105Sarclisa $103Trodelvy $102Fabhalta $98.96Balversa $98.39Ibrance $98.39Xpovio $93.05Welireg $89.61Comirnaty $84.92Rezlidhia $82.12Tavalisse $82.12Braftovi $82.09Mektovi $82.09Akeega $79.51Inlyta $78.21Ninlaro $73.89Carvykti $67.31Opdualag $66.29Optune Lua (Novottf-200t) $63.80Yescarta $58.50Polivy $58.41Tasigna $58.33Bracanalysis Cdx $55.94Bavencio $55.66Tibsovo $53.89Promacta $52.58Paxlovid $52.01Stivarga $51.72Vitrakvi $51.72Cabometyx $51.09Fotivda $50.06Tolmetin Sodium $48.84Orphenadrine Citrate, Aspirin and Caffeine $48.84Ultomiris $48.41Rytelo $48.12Rolvedon $46.81Nerlynx $46.26Lorbrena $45.43Tevimbra $44.22Vonjo $41.50Pyrukynd $40.36Pomalyst $39.34Lunsumio $36.29Columvi $36.29Jemperli $36.20Voquezna $35.75Ojjaara $34.88Inqovi $33.58Lonsurf $33.58Blincyto $33.53Onivyde $29.13Somatuline Depot $29.13Amtagvi $26.35Pylarify $26.21Endari $26.17Tecentriq Hybreza $25.48Tecentriq $25.48
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.